P01	CLINICAL PREDICTIVE MARKERS IN RITUXIMAB RELATED LATE-ONSET NEUTROPENIA Ali Oğul, Semra Paydaş, Mahmut Büyükşimşek, Abdullah Evren Yetişir, Cem Mirili,
P02	HEPATITIS B AND C POSITIVITY RATES IN SOLID TUMORS AND REACTIVATION RATES DUE TO CYTOTOXIC CHEMOTHERAPY Mustafa Karaca, Deniz Tural, Gülsüm Özet, Orhan Kemal Yücel, Armağan Aydin, Aytuğ Üner, Ahmet Özet
P03	SOLID ORGAN CANCERS IN RENAL TRANSPLANT RECIEPIENTS: SINGLE CENTER EXPERIENCE DERYA KIVRAK SALİM, HASAN ŞENOL COŞKUN, SEMA SEZGİN GÖKSU,
P04	ANXIETY AND DEPRESSION DISORDERS IN ONCOLOGY PATIENTS Özlem Er, Deniz İnanıcı,
P05	USEFULNESS OF FDG-PET/CT IN ONGOING RISK STRATIFICATION OF HIGH/INTERMEDIATE RECURRENCE RISK DIFFERENTIATED THYROID CARCINOMA PATIENTS Umut Elboga, Ertan Sahin, Y.Zeki Celen,
P06	PROGNOSTIC IMPORTANCE OF TUMOR LOCATION AND ANTI-EGFR THERAPY IN PATIENTS WITH RAS WILD TYPE METASTATIC COLORECTAL CANCER Mehmet Küçüköner, E Öztekin, N Akdeniz, H Yerlikaya, Z Urakci, M A Kaplan, A Işıkdoğan,
P07	CLASS III BETA-TUBULIN EXPRESSION LEVEL AS PROGNOSTICS AND PREDICTIVE BIOMARKER IN BREAST CANCER PATIENTS Leyla Arastun Melikova, Elchin Bilal mansurov, Elnara Eldar bagirova, Zeynab Qambar Allahverdiyeva, Elnura Vali Qasimova, Sabina Qambar Mehdizadeh,
P08	INVESTIGATION OF CYCLIN E1 (CCNE1) GENE EXPRESSION STATUS IN LARYNGEAL SQUAMOUS CELL CARCINOMA Semra Demokan, Sena Şen, Önder Eryılmaz, Sevde Cömert, Yusufhan Suoğlu, Murat Ulusan, Gülsüm Ak, Nejat Dalay,
P09	BREAST CANCER STAGE III C: THE PHARMACOGENETICS APPROACH TO BREAST CANCER TREATMENT Jamil Aziz Aliyev, Sevinj Ilqar Ragimzade, Elchin Bilal Mansurov, Leyla Arastun Melikova,